
News|Videos|August 31, 2023
Chapter 4. Optimal Treatment Outcomes for Treating Patients With ADHD
Sponsored by: Ironshore Pharmaceuticals
Episodes in this series

IP001858 08/23
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Latest CME
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
Increased Risk of Death in Patients With Dementia Found Related to Common Hospice Medications
4
The Use of Aripiprazole for Bipolar Disorder
5